The specific biochemical reaction that initiated the process is a T-cell-mediated delayed hypersensitivity reaction, which begins with the binding of the anticonvulsant drug or its metabolite to a specific Human Leukocyte Antigen (HLA) protein, leading to the activation of cytotoxic T-lymphocytes.